FOXP3 and myeloid sarcoma: By contrast, the presence of FoxP3+ cells was not initially detected at any type of MS lesions [117], and subsequent analysis of the distribution of FoxP3+ cells in MS tissue confirmed the scarcity of these regulatory cells, with FoxP3 staining only witnessed in 70% of patients [118,119].